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Lamins A, B, and C are the major proteins of a polymeric 
structure called nuclear lamina, which is intercalated be-
tween chromatin and the inner membrane of the nuclear 
envelope. Using immunofluorescence on HEp-2 cells, spe-
cific enzyme-linked immunosorbent assay, and Western 
blotting performed against nuclear lami~a preparation .from 
Ehrlich ascites tumor cells, we charactenzed three patients, 
whose sera contained antibodies to nuclear lamins. The reac-
T he presence of autoantibodies against nuclear struc-tures is a characteristic feature of many autoimmune diseases [1]. Moreover, antinuclear antibodies (ANA) with different antigenic specificities have been found to characterize specific diseases. The pathogenic and 
biolog ic roles of these antibodies remain unknown, but some of the 
antibodies have proved to be useful reagents for the characterization 
of specific nuclear proteins. Examples of this include the autoanti-
body to Scl-70 found in patients with scleroderma [2J, which has 
been shown to target DNA topoisomerase I as antigen [3], or the 
autoantibody to proliferating cell nuclear antigen {PCNA)/cyclin 
in systemic lupus erythematosus (SLE) [4], which is now known to 
recognize the auxiliary protein.of DNA polyme~ase. t5 [5J: 
ANA in human sera are routInely detected by Il1dlrect Immuno-
fluorescence microscopy on substrates such as tissue cryostate sec-
tions or various types of cultured human cell lines. Among the 
patterns identified by this method, the peripheral ANA l?attern has 
been thought to be of diag nostic importance because of Its correla-
tion with SLE and autoantibodies to dsDNA [6]. Recently, an associ-
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tion pattern observed in two of the patients may result fro m 
sing1e or combined occurrence of anti-Iamin A and C anti-
bodies. The third patient had antibodies that probably recog-
nized an epitope in the carboxy-terminal region of lamin C. 
The sera were donated by a heterogeneous group of patients, 
and no common clinical or laboratory signs seemed to link 
them together.] Invest DermatoI95:304-308, 1990 
ation of a peripheral fluorescent ANA pattern and antibodies ro 
nuclear lamins was reported [7,8]. 
The nuclear lamina (NL) is a proteinaceus layer or meshwork, 
which lines the nucleoplasmic surface of the inner nuclear mem-
brane [9}. It is an important karyoskeletal structure formed by a 
polymer, containing three polypeptides with molecular masses be-
tween 60 and 75 kDa, termed lamins A, B, and C PO]. The NL is 
presumed to rrovide both architectural framework for the nuclear 
envelope [11 and attachment points at the nuclear periphery for 
interphase chromatin [12]. Thus, nuclear lamins are consider 
DNA-binding proteins, with possible influence on basic cellular 
functions, including DNA replication and gene transcription. Im-
munocytochemical studies indicate that the lamina is present in 
nearly all interphase nuclei, at least in higher eukaryotes [13]. Al-
though highly stable in interphase cells, the NL is rapidly and revers-
ibly depolymerized during mitotic prophase, presumably through 
transient hyperphosphorylation of the individuallamins [14) . It has 
also been shown that the lamins are members of the intermediate 
filament protein family [15]. On the basis of peptide maps and 
immunologic cross-reactivity [16,17), lamins A and C appear to be 
closely related, whereas lamin B has a different structure. However, 
certain monoclonal antibodies cross-react with all three lamins, in-
dicating that some epitopes are shared by all three of them [18J. 
Immunoblotting analyses have shown that connective tissue disease 
sera recognize both A/C [7] and B [8] lamins. 
The aim of the present study was to establish a sensitive enzyme-
linked immunosorbent assay (ELISA) and immunoblotting to ass 
the IgG antibodies to NL preparation from Ehrlich ascites tumor 
(EAT) cells in serum samples from patients showing a continuous 
peripheral (membranal) nuclear immunofluorescence. W e al 
tried to determine whether indirect imullofluorescence differentia-
tion of these antibodies may be possible in the setting of a routin~ 
laboratory using standard ANA substrates. Finally, we wanted 
look at the clinical diagnoses and organ manifestations related 
presence of anti-lamin antibodies. 
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MATERIALS AND METHODS 
Sera Sera fro m 600 patients with suspected collagen vascul ar dis-
eases were screened by immunofluorescence for peripheral, linear 
staining of the nuclear enve lope. Three sera that were strongly 
positive were selected for further study. 
Indirect Immunofluorescence The presence of ANA was de-
termined using commercial HEp-2 ANA slides (Immunoconcepts, 
Sacramento, CAl, and the indirect immunofluorescence assay was 
performed usi ng FITC-Iabeled anti-human IgG conjugate (Dako-
pacts F-202, Copenhagen, Denmark). Sera that display continuous 
peripheral pattern of nuclear fluorescence were also assayed on 
cryostate sections of rat liver as substrate [1 9]. Antibodies to dsDNA 
were tested by the Crithidia luciliae immunofluorescent (CL-IF) 
assay as described by Aard en et al [20J using the same conjugate. 
Preparation of Nuclear Lamina Fraction NL proteins were 
obtained from EAT cel ls by the method ofKraclll11arov et al [21], as 
described previously [22J. The procedure involves dispersing the 
cytoplas m by treatment with Nonidet P-40 at low ionic strength 
and diges tion of the nuclear structures with DNase II and RNase in 
[he absence of divalent cations. The procedure yields intact NL 
shells, essentially depleted of intranuclear material and nuclear 
membranes. The isolated NL by this method has been previously 
characterized by electron microscopic, biochemical, and immuno-
chemical techniques [21,22] . It contains three major polypeptides, 
identi.fied previous ly as lamin A, B, and C, with molecular masses of 
71,68, and 64 kDa, respectively, and a fraction identified as vimen-
[in (58 kDa) with its degradation products. 
Preparation of Antisera to NL Proteins Antibodies against 
NL proteins isolated from EAT cells [21 ,22J were raised in chick-
ens. Electrophore tically purified lamins Band C were used as anti-
gens. The details of the immunization procedure were as previously 
described [22] . Antibodies against chicken IgG fraction used as sec-
ond antibody in ELISA were elicited in rabbits. FPLC purified IgG 
from chicken serum was used as antigen. Both antisera were diluted 
1 : 100,000 for ELISA. 
ELISA The ELISA was performed as follows. Flat-bottomed mi-
crotiter plates (Nunc, Denmark) were coated by overnight incuba-
cion w ith 1 ,ugj l111 of NL proteins in 0.1001111 phosphate-buffered 
saline (PBS). The plates were washed twice in PBS with 0.05% 
Triton X-100, blocked with 1 % bovine serum albumin (BSA) in 
PBS for 2 h at 37 °C, and washed again. Duplicate serum samples 
diluted 1 : 100, 1 : 500, and 1: 1000 were added at 0.100 mlj well in 
PBS, 0.1 % BSA, 0.05% Triton X-100 and incubated for 2.5 h at 
37"C. After rinsing the plates with PBS, 0.05% Triton X-lOO 5 
rimes for 5 min each on a shaker, peroxidase-conjugated goat anti-
bodies to human IgGjgamma chain speci.fic (Tago, Burlingame, 
CA) diluted 1 : 1500 in PBS, 0.1 % BSA, 0.05% Triton X-IOO were 
added and incubated for 1 h at 3rc. After a final wash, 0.033% 
o-phenylendiam.ine (Sigma, St. Louis, MO) in a citric/phosphate 
buffer, pH 5.6, containing 0.03% Hz0 2 , was used to develop the 
peroxidase reaction. The reaction was stopped by adding 0.05 ml 
2N H 2S04 , and the adsorbance at 492 nm was detected on a plate 
reading spectrophotometer (Easy Reader, STL-Labinstruments, 
Austria). 
To control antigen binding to the solid phase, three step ELISA 
with antibodies to NL proteins raised in chickens and rabbit anti-
chicken IgG were performed as described above. 
Immunoblotting Immunoblotting experiments were per-
formed by the method of Towbin et al [23J . Polypeptides resolved 
inSDSjl0% polyacrylam.id gel were e1ectrophoretically transferred 
to nitrocellulose paper (0.45,um, Millipore) in a " tris"-gl ycine 
buffer, pH 8.3, for 4 h at 70 V. A side portion of the blot was stained 
with 0 .1 % amidoblack in 4% acetic acid, 40% methanol. After a 2-h 
blocking of remaining protein binding sites on the membrane with 
1% BSA, tbe blots were probed with human test sera at a dilution of 
1: 50 co 1: 100 for 2 h at room temperature. The nitrocellulose was 
AUTOANTIBODIES TO NUCLEAR LAMINS A AND C 305 
Figure 1. Indirect immunofluorescence stain ing of HEp-2 cells using 
serum from patient H] (dilution 1 : 160). a: sta ining of interphase cel ls show-
ing peripheral (membranal) pattern of nuclear fluorescence; b: the mem-
branal staining is not visible in the chromosome region of metaphase mitotic 
ce lls. 
then washed extensively 3 times 5 min each on a shaker with PBS 
containing 0.5 m NaCI, 0.05 % T ween 20, and peroxidase-conju-
ga ted second antibody (same as for ELISA) was applied, diluted 
1 : 1000 in washing buffer. After five washes, as described above, 
color development with o-dianisidine (Sigma, St. Louis , MO) was 
allowed to proceed for 5 - 10 min at room temperature. Control 
lanes of nitrocellulose without any serum or without anti-human 
IgG were run in parallel in all experiments. 
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Clinical Evaluation Complete clinical, biologic, and therapeu-
tic records were available for all the patients studied. Diagnoses 
were made according to established criteria. 
RESULTS 
Indirect Immunofluorescence Among 600 patients with sus-
pected rheumatic diseases, we identified three whose sera stained 
the nuclear periphery of human HEp-2 cells. On HEp-2 interphase 
nuclei, this pattern of staining clearly delineated the nucleus from 
the cytoplasm. During cell division the membranal staining was not 
visible, and there was no staining in the chromosome region of 
metaphase mitotic cells (sera No. 1360 and No. 1541; Fig 1). Serum 
No. 844 stained the condensed chromosomes in mitotic cells as it 
also contained anti-dsDNA antibodies, confirmed by the assay on 
Crithidia species. The three sera had an end ANA titer of 1 : 640. On 
rat liver tissue sections the sera produced bright peripheral nuclear 
staining, and the end titer was much lower compared to HEp-2 
cells. 
The fluorescence pattern observed suggested that the three sera 
contained antibodies directed against the nuclear envelope, whose 
structural components include a double membrane, pore com-
plexes, and the NL. The latter possibility was tested by ELISA and 
immunoblotting. 
ELISA Preliminary experiments defined the optimal antigen 
concentration used in ELISA as 1 f1g/ml ofNL proteins from EAT 
cells. Control studies were performed with either no antigen, nor-
mal serum, or serum from HEp-2 ANA negative rheumatic pa-
tients. Values (given as the extinction measured) that were 2 times 
or more than those of controls in all three dilutions were scored as 
positive. The binding of antigen to the solid phase was tested in the 
same ELISA conditions with specific antisera to NL raised in ani-
mals .. Positive reaction was detected even when the antisera were 
diluted 1: 100,000. 
In the samples studied, sera from the three patients, selected on 
the basis of their staining pattern on HEp-2 cells, were found to have 
IgG anti-NL antibodies, whereas all controls showed negative re-
sults. 
Immunoblotting To further define the specific NL antigens 
bound by these sera, immunoblot experiments were performed. 
Nitrocellulose transfers ofNL proteins separated by polyacrylamide 
gel electrophoresis were probed with the human sera that were 
ELISA positive for NL antibodies. Figure 2 shows the immunoblot-
ting results with the NL preparation fr0111 EAT cells as antigen. As 
seen in this figure, none of the sera recognized lamin B. Serum No. 
844/lal1e 2 and serum No. 1360/lal1e 3 recognized both lamin A and 
lamin C. Despite the high percent of structural homology between 
these two lamina proteins, our sera stained one of them much 
darker. This has been even more apparent with serum No. 
1541/lal1e 4, which showed reactivity associated exclusively with a 
lamin C epitope. 
Clinical Studies The clinical charts of the patients were studied 
retrospectively. 
Patiel1t SC: Serum No. 844 was obtained from a 25-year-old 
woman, who was diagnosed as suffering from SLE. She did satisfy 
the revised diagnostic criteria of the American Rheumatism Associa-
tion (AM) for this disease [24), presenting with pericarditis, 
thrombocytopenia, positive ANA, and anti-dsDNA antibodies. In 
addition, she also had arthralgia, false p()sitive serologic test for 
syphilis, positive Coombs, and hypocomplementemia C4. No clin-
ical or laboratory features for liver disease were present. 
Patient IT: Serum No. 1360 was obtained from a 61-year-old wo-
man with hypermobility syndrome. She also had radiologic signs of 
osteoarthrosis of the distal interphalangeal joints and in her knees, 
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Figure 2. W estern blots of nuclear lamina preparation from Ehrlich ascit~ 
tumor ce lls as antigen source. Lalit! 1: amidoblack stain; latles 2 - 4: blots with. 
patients sera. Positions of the nuclear lamins A, B, and C and vimenrin ('? 
are as indicated. 
but no evidence of inflammatory arthropathy. The liver was not 
palpable, and the liver enzymes were within normal limits. No 
abnormalities were found on her laboratory tests, including IgM 
rheumatoid factor. 
Patient HI: Serum No. 1541 was obtained fr()m a 39-year-old wo-
man witrl symmetrical arthralgias of the fingers and knees of 1 year 
duration, but without swelling of the joints. Results of the physical 
exar,nination were normal. Except for a positive ANA, repeated 
laboratory evaluation was unremarkable, including liver enzyme 
levels. The patient's medical history was non-contributory and 
there was no family history of connective tissue diseases. 
DISCUSSION 
In view of their diagnostic importance, ANA are the subject of 
intensive research. There has been considerable interest in autoanti. 
bodies directed against nucleic acids, nucleic acid protein com. 
plexes, or enzymes and factors involved in their metabolism. In 
contrast, antibodies directed against the nuclear envelope are still 
not extensively examined, and their true prevalence is not known. 
Serum autoantibodies to all three mammalian lamins have been 
found in a smaIl group of patients with variety of diseases, includin 
linear scleroderma [7), SLE [8 ,25)' autoimmune liver diseast 
[26,27), and in a heterogeneous group of patients with blood cytO-
penia, hepatitis and brain or skin vasculitis (281. The clinical signifi. 
cance of the anti-NL antibodies has not been fully established. It h 
been proposed that the common clinical feature in all patients wi 
these antibodies might be chronic autoimmune liver disease wi 
other associated clinical features [29]. 
The present study identifies three other patients with anti- l 
antibodies. Samples from them were analyzed by immunofluor . 
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cence tes tin g with H Ep-2 cells and rat liver sections, ELISA, and 
immunoblotting performed against NL proteins separated by po-
Iyacrylamid gel electrophoresis. As initial screen fo r anti-NL anti -
bodies we have used immunofluorescence on H Ep-2 substrate. Be-
cause the NL is located between the ch rom atin and the inner 
nuclear m em brane, antibodies reacting w ith the lamins produce a 
periphera l pa tte rn of fluo rescence in the flu orescent ANA assay. 
The linea r stain ing of th e nucl ear envelope was no t visible in divid-
ing cells, as it is presumed that in response to metaphase-specific 
phosphorylation events t he lamin proteins trans ientl y depolymerize 
into solubl e o li go meric subunits. Testin g on HEp-2 cells provided a 
clue to th e possibl e antigen specific ity o f th e antibodies leading to 
peripheral nucl ea r stainin g, due to th e presence of cells in various 
stages of cel l divisio n in the tes t substra te and the cell cycle dynamics 
ofNL's integri ry. As sera from human autoimmune disease patients 
genera lly tend to contain mul tip le autoa ntibodies, screenin g for 
anti-lamin antibodies by indirect im m unoflu orescence may under-
estimate t heir freq uency, because sera containing both anti-lamin 
and anti-DNA ca nnot be d istinguished fro m sera co ntaining anti-
DNA only [30]. C ryos tate rat liver sectio ns used for routine ANA 
testing do not discrim inate betwee n antibodies aga inst dsDNA, nu-
clear lamins, or th e pore co mplexes [31]. all of w hich can stain the 
nuclear perip hery. As o nly one of our patients had SLE, our results 
also ind icate that the periphera l flu orescent ANA pattern should be 
interpreted w ith cautio n regard ing the diagnosis of SLE, especially 
in diagnostica ll y problematic cases, as it may be observed in other 
diseases too. 
In general, the immunofluo rescent staining patterns sometimes 
may be difficult to interpret , and leading to only an approximate 
antibody titer. T he E LISA, more recently developed, is a rapid , 
rela tively simple method of easy measurement. Because the lamins 
are large ly insolubl e in physio logic buffers because of their po ly-
meric structure [9]' w e have checked in our sys tem the binding of 
the antigen to the polys terene surface of the solid phase with spe-
cinc antisera raised in chickens. The positive reactio n obtained at 
di lution 1 : 100 ,000 of the antibodies and the low background, 
proved the coating step efficiency. The results of th e ELISA that are 
presented in th is study indicate th at th e assay m ay represent a p racti-
cal and sensitive means fo r the detection of specific anti-NL antibod-
ies on a larger scale th at makes it possible to avoid disturbances of 
antinuclear and anticytoplasmic antibodies likely to take place in the 
indirect immunoflu orescence technique. 
To identi fy the specific protein targets bound by the three test 
sera, immunoblotting experiments were performed. The presence 
of antibodies reacting specificall y with lamins A and C, but not with 
lamin B, is no t surprising, as the complete nucleotide sequence of 
the coding regio n of the A and C lamins shows that these proteins 
are identical except for their carboxy-termini . In fac t, the first 566 
amino acids of the A and C lamins are identical, after which lamin C 
contains an additional six carboxy l-terminal amino acids, whereas 
lamin A contains an additional 98 amino acids [32]. It appears that 
one of our patients has autoantibodies that recognize an epitope in 
the carboxy-terminal region of lamin C; as cross reaction with la-
min A is evidently missin g. The presence of antibodies solely recog-
nizing nuclear lamin C has been reported recently in patients with 
chronic hepati tis delta virus infection [27]. 
The present study demonstrates that the sera from three out of six 
hundred patients with suspected rheumatic diseases contain antibod-
ies that are specific for the A/C or C polypeptides of the N L. These 
sera were donated by a heterogeneous group of patients, none of 
wh ich suffered from liver d isease, w hich has been proposed as a 
factor, driving autoimmune n;:sponse to th e NL proteins. No com-
mon clinical or laboratory signs seemed to link these three patients 
together. The titer level of th e anti -NL antibodies also seems no t to 
bear significance for the extent of th e clinical symptomatology 
presented. Because the anti-NL ELISA has no t been used as ye t fo r 
scree ning of sera, the frequency of the anti-lamin antibodies may be 
higher than foun d w it h the less sensitive immunofluo rescence tech-
nique , and their cl inica l associa tions still rem ain to be established. 
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Knowledge of the lamin proteins acting as autoantigens w ill also 
give some insig ht in the nature of autoimmunity. 
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